Related Experiment Video
Updated: Mar 13, 2026
07:03
Large Scale Zebrafish-Based In vivo Small Molecule Screen
Published on: December 30, 2010
14.1K
Zebrafish small molecule screens: Taking the phenotypic plunge
Charles H Williams1, Charles C Hong2
1Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Computational and Structural Biotechnology Journal
|October 11, 2016
Summary
Phenotypic screens offer a powerful alternative to traditional target-based drug discovery, improving R&D efficiency. Zebrafish models are particularly effective for in vivo phenotypic screening, advancing therapeutic development.
Area of Science:
- Drug discovery and development
- Genetics and genomics
- Translational medicine
Background:
- Traditional target-based chemical screens face declining R&D efficiency.
- Phenotypic screens are increasingly accepted as a complementary or alternative approach.
- Advances in genetics and data analysis are reshaping drug discovery.
Approach:
- Discusses various model organisms for phenotypic screening.
- Highlights zebrafish as a leading model for in vivo phenotypic screens.
- Explores therapeutic opportunities in rare diseases.
Key Points:
- Phenotypic screens complement or replace target-based approaches.
- Zebrafish offer a robust model for in vivo phenotypic drug discovery.
- Integration of Mendelian genetics, EHR data, and genome editing drives innovation.
Conclusions:
- Phenotypic screening, especially using zebrafish, enhances drug discovery efficiency.
- Leveraging genetic and health data identifies novel therapeutic avenues, particularly for orphan diseases.
- This approach holds promise for addressing unmet medical needs in rare genetic conditions.
